Comparison of amitriptyline metabolism in hepatocytes from streptozocin-induced diabetic rats and from non-diabetic rats

Cell Biology and Toxicology

Volumn 13, Issue 2, 1997, Pages 131-137

  Coudore F ^a   Besson, A ^a   Shrivastava, R ^c   Chevalier, A ^c   Eschalier, A ^b   Lavarenne, J ^b   Massingham, R ^c   Fialip, J ^a  

^a Faculte de Pharmacie   (France)

^b UNIVERSITÉ CLERMONT AUVERGNE   (France)

^c CERM Centre Europeen de Recherches Mauvernay   (France)

Author keywords

antidepressant; biotransformation; cell culture; diabetes; kinetics; rat

Indexed keywords

AMITRIPTYLINE; DRUG METABOLITE; NORTRIPTYLINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG GLUCURONIDATION; DRUG HYDROXYLATION; DRUG METABOLISM; LIVER CELL CULTURE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; STREPTOZOCIN DIABETES;

AMITRIPTYLINE; ANIMALS; CELLS, CULTURED; DIABETES MELLITUS, EXPERIMENTAL; GLUCURONIDASE; LIVER; MALE; RATS; RATS, SPRAGUE-DAWLEY; STREPTOZOCIN; TIME FACTORS;

ANIMALIA;

EID: 0031036584     PISSN: 07422091     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:CBTO.0000010398.63757.4c     Document Type: Article

References (28)

1. Balant-Gorgia AE, Schultz P, Dayer P, Balant L, Kubli A. Role of oxidation polymorphism on blood and urine concentrations of amitriptyline and its metabolites in man. Arch Psych Nervenkr. 1982;232:215-22.
2. Breyer-Pfaff U, Prox A, Wachsmuth H, Yao P. Phenolic metabolites of amitriptyline and nortriptyline in rat bile. Drug Metab Dispos. 1987;15:882-9.
3. Coudoré F, Ardid D, Eschalier A, Fialip J, Lavarenne J. High-performance liquid chromatographic determination of amitriptyline and its main metabolites using a silica column with reversed-phase eluent. J Chromatogr Biomed Appl. 1992;584:249-55.
4. Coudoré F, Fialip J, Eschalier A, Lavarenne J. Mice plasma and brain pharmacokinetics of amitriptyline and its demethylated and hydroxylated metabolites after half-life repeated administration. Fundam Clin Pharmacol. 1994;8:525-31.
5. Coudoré F, Besson A, Courteix C, Eschalier A, Lavarenne J, Fialip J. Pharmacokinetics of amitriptyline and its demethylated and hydroxylated metabolites in streptozocin-induced diabetic rats. Gen Pharmacol. 1996;27 (in press).
6. Courteix C, Eschalier A, Lavarenne J. Streptozocin-induced diabetic rats: behavioural evidence for a model of chronic pain. Pain. 1993;53:81-8.
7. Courteix C, Bardin M, Chantelauze C, Lavarenne J, Eschalier A. Study of the sensibility of the diabetes-induced pain model in rats to a range of analgesics. Pain. 1994;57:153-60.
8. Dahl ML, Bertilsson L. Genetically variable metabolism of antidepressants and neuroleptic drugs in man. Pharmacogenetics. 1993;3:61-70.
9. Dahl-Puustinen ML, Bertilsson L. Formation of quaternary N-glucuronide of amitriptyline in human liver microsomes. Pharmacol Toxicol. 1987;61:342-6.
10. Dumont E, Von Bahr C, Perry TL, Bertilsson L. Glucuronidation of the enantiomers of E-10-hydroxy-nortriptyline in human and rat liver microsomes. Pharmacol Toxicol. 1987;61:335-41.
11. Favreau LV, Schenkman JB. Composition changes in hepatic microsomal cytochrome P-450 during onset of streptozocin-induced diabetes and during insulin treatment. Diabetes. 1988;37:577-84.
12. Kroemer HK, Klotz U. Glucuronidation of drugs. A reevaluation of the pharmacological significance of the conjugates and modulating factors. Clin Pharmacokinet. 1992;23:292-310.
13. Kruger R, Holzl G, Kuss HJ, Schefold L. Comparison of the metabolism of the three antidepressants amitriptyline, imi-pramine, and chlorimipramine in vitro in rat liver microsomes. Psychopharmacol. 1986;88:505-13.
14. Imaoka S, Nakamura M, Ishizaki T et al. Regulation of renal cytochrome P450s by thyroid hormone in diabetic rats. Biochem Pharmacol. 1993;46:2197-200.
15. Mellstrom B, Von Bahr C. Demethylation and hydroxylation of amitriptyline, nortriptyline, and 10-hydroxyamitriptyline in human liver microsomes. Drug Metab Dispos. 1981;9:565-8.
16. Moldeus P, Hogberg J, Orrhenius S. Isolation and use of liver cells. Methods Enzymol. 1978;52:60-71.
17. Murray M. P450 enzymes. Inhibition mechanisms, genetic regulation and effects of liver disease. Clin Pharmacokinet. 1992;23:132-46.
18. Nielsen KK, Brosen K, Gram LF. Steady-state plasma levels of clomipramine and its metabolites: impact of the sparteine/debrisoquine oxidation polymorphism. Eur J Clin Pharmacol. 1992;43:405-11.
19. Nordin C, Bertilsson L. Active hydroxymetabolites of antidepressants. Emphasis on E-10-hydroxy-nortriptyline. Clin Pharmacokinet. 1995;28:26-40.
20. Rouer E, Leroux JP. Liver microsomal cytochrome P-450 and related monooxygenase activities in genetically hyperglycemie (ob/ob and db/db) and lean streptozotocin-treated mice. Biochem Pharmacol. 1980;29:1959-62.
21. Rouer E, Mahu JL, Columelli S, Dansette P, Leroux JP. Induction of drug metabolizing enzymes in the liver of diabetic mice. Biochimie. 1982;64:961-7.
22. Rouer E, Delaforge M, Rocchiccioli F, Gibson GG, Leroux JP. Spin state studies on cytochrome P-450 in liver microsomes from obese and diabetic animals. Biochem Biophys Res Commun. 1985;1:615-21.
23. Rouer E, Beaune P, Leroux JP. Immunoquantitation of some cytochrome P-450 isozymes in liver microsomes from streptozotocin-diabetic rats. Experientia. 1986;42:1162-3.
24. Rouer E, Rouet P, Leroux JP. Microsomal aldrin epoxidase activity in liver of diabetic (insulin deficient) rats and studies of its regulation by glucagon in isolated hepatocytes. In: Guillouzo A, ed. Liver cells and drugs. Colloque Inserm/J. Libbey Eurotext Ltd; 1988;64:263-8.
25. Shimojo N. Cytochrome P450 changes in rats with streptozocin-induced diabetes. Int J Biochem. 1994;26:1261-8.
26. Skett P, Joels LA. Different effects of acute and chronic diabetes mellitus on hepatic drug metabolism in the rat. Biochem Pharmacol. 1985;34:287-9.
27. Wrighton SA, Stevens JC. The human hepatic cytochromes P450 involved in drug metabolism. Crit Rev Toxicol. 1992;22:1-21.
28. Young RC. Hydroxylated metabolites of antidepressants. Psychopharmacol Bull. 1991;27:521-30.